Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients.
Dalla Volta A, Caramella I, Di Mauro P, Bergamini M, Cosentini D, Valcamonico F, Cappelli C, Laganà M, Di Meo N, Farina D, Pedersini R, Mazziotti G, Berruti A. Dalla Volta A, et al. Among authors: berruti a. Curr Oncol Rep. 2023 Oct;25(10):1141-1152. doi: 10.1007/s11912-023-01447-9. Epub 2023 Aug 25. Curr Oncol Rep. 2023. PMID: 37624550 Free PMC article. Review.
FSCN1 as a new druggable target in adrenocortical carcinoma.
Ruggiero C, Tamburello M, Rossini E, Zini S, Durand N, Cantini G, Cioppi F, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Landwehr LS, Weigand I, Kurlbaum M, Zizioli D, Turtoi A, Yang S, Berruti A, Luconi M, Sigala S, Lalli E. Ruggiero C, et al. Among authors: berruti a. Int J Cancer. 2023 Jul 1;153(1):210-223. doi: 10.1002/ijc.34526. Epub 2023 Mar 31. Int J Cancer. 2023. PMID: 36971100
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.
Esposito E, Marra G, Catalano R, Maioli S, Nozza E, Barbieri AM, Hantel C, Di Dalmazi G, Sigala S, Geginat J, Cassinotti E, Baldari L, Palmieri S, Mangone A, Berruti A, Ferrante E, Mantovani G, Peverelli E. Esposito E, et al. Among authors: berruti a. Int J Cancer. 2025 Mar 15;156(6):1256-1271. doi: 10.1002/ijc.35239. Epub 2024 Nov 11. Int J Cancer. 2025. PMID: 39528354 Free PMC article.
Adjuvant denosumab for early breast cancer-Evidence and controversy.
Moretti L, Richelmi L, Cosentini D, Pedersini R, Grisanti S, Amoroso V, Berruti A, Laganà M. Moretti L, et al. Among authors: berruti a. Breast. 2024 Dec;78:103826. doi: 10.1016/j.breast.2024.103826. Epub 2024 Oct 23. Breast. 2024. PMID: 39509862 Free PMC article.
Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Hadoux J, Lamarca A, Grande E, Deandreis D, Kaltsas G, Janson ET, Tombal B, Pavel M, Thariat J, van Velthuysen MF, Herman P, Dromain C, Baudin E, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Hadoux J, et al. Among authors: berruti a. ESMO Open. 2024 Oct;9(10):103664. doi: 10.1016/j.esmoop.2024.103664. Epub 2024 Oct 1. ESMO Open. 2024. PMID: 39461777 Free PMC article.
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?
Pedersini R, Schivardi G, Laganà M, Laini L, di Mauro P, Zamparini M, Amoroso V, Bonalumi A, Bosio S, Zanini B, Buizza C, Villa N, Ravanelli M, Rinaudo L, Grisanti S, Farina D, Berruti A, Donato F, Cosentini D. Pedersini R, et al. Among authors: berruti a. Breast. 2024 Dec;78:103794. doi: 10.1016/j.breast.2024.103794. Epub 2024 Aug 31. Breast. 2024. PMID: 39265313 Free PMC article.
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples.
Arakawa Y, Elloumi F, Varma S, Khandagale P, Jo U, Kumar S, Roper N, Reinhold WC, Robey RW, Takebe N, Gottesman MM, Thomas CJ, Boeva V, Berruti A, Abate A, Tamburello M, Sigala S, Hantel C, Weigand I, Wierman ME, Kiseljak-Vassiliades K, Del Rivero J, Pommier Y. Arakawa Y, et al. Among authors: berruti a. Cancer Res Commun. 2024 Sep 1;4(9):2384-2398. doi: 10.1158/2767-9764.CRC-24-0100. Cancer Res Commun. 2024. PMID: 39162009 Free PMC article.
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group.
Fabbroni C, Grignani G, Vincenzi B, Fumagalli E, De Pas TM, Mazzocca A, Pantaleo MA, Brunello A, Baldi GG, Boglione A, Fatigoni S, Berruti A, Giordano M, Marrari A, Dei Tos AP, Alberton AS, Aliberti S, Carlucci L, Rulli E, Casali PG, Sanfilippo R. Fabbroni C, et al. Among authors: berruti a. ESMO Open. 2024 Aug;9(8):103667. doi: 10.1016/j.esmoop.2024.103667. Epub 2024 Aug 8. ESMO Open. 2024. PMID: 39121815 Free PMC article. Clinical Trial.
534 results